US Edition
Changes in antibiotic use associated with the National Centralized Drug Procurement policy in China from 2019 to 2023 - AMR Insights
Summary by AMR Insights
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Changes in antibiotic use associated with the National Centralized Drug Procurement policy in China from 2019 to 2023 - AMR Insights
The study examines changes in antibiotic use under the National Centralized Drug Procurement Policy (NCDP) in four medical institutions in Central, Western, and Eastern China. It found that the policy primarily influenced the substitution of non-NCDP varieties with NCDP varieties in inpatient settings, leading to a decline in overall and injectable antibiotic utilization rates. Regular monitoring and management are crucial for optimizing antibio…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
